Table 2.

Hematologic toxicities of 13 patients treated with AZT, GCV, rituximab, and dexamethasone^*

	Induction				Maintenance
	Grade 1 N (%)	Grade 2 N (%)	Grade 3 N (%)	Grade 4 N (%)	Grade 1 N (%)	Grade 2 N (%)	Grade 3 N (%)	Grade 4 N (%)
Anemia	0 (0)	0 (0)	1 (7.7)	0 (0)	0 (0)	0 (0)	2 (15)	2 (15)
Leukopenia	3 (23)	2 (15)	3 (23)	0 (0)	0 (0)	5 (38)	2 (15)	2 (15)
Lymphopenia	0 (0)	1 (7.7)	0 (0)	0 (0)	1 (7.7)	1 (7.7)	1 (7.7)	0 (0)
Neutropenia	3 (23)	0 (0)	1 (7.7)	2 (15)	3 (23)	0 (0)	3 (23)	2 (15)
Thrombocytopenia	3 (23)	0 (0)	0 (0)	0 (0)	3 (23)	1 (7.7)	0 (0)	2 (15)

^*Toxicities were determined according to the National Cancer Institute Common Terminology Criteria Version 4.0